ART In Europe

ART In Europe

We know that the cancellation and postponement of treatment due to Covid 19 has brought untold stress and disappointment for our patients and for those all across Europe – see map released by ESHRE on 20/04/20.

But there are signs that activity is resuming as Denmark, Germany and the Netherlands slowly recommence services. We in MFC hope to also commence treatments in May, if the current trends in suppression of the virus continue and if national restrictions begin to ease. This will have to begin slowly and under strict guidelines and we will update our website as things progress.

In the meantime, don’t lose hope, try to optimise your health and wellbeing and don’t hesitate to contact our team of caring professionals if you have any queries or concerns.

http://www.eshre.eu/COVID19WG

 

 

New MFC Research Study

Anti-Müllerian hormone

New MFC research study suggests that Anti-Müllerian hormone and progesterone levels in human follicular fluid are predictors of embryonic development.

A recent study from Dr Yvonne O’ Brien, from her time with MFC, has found that AMH and progesterone levels are higher in follicular fluid surrounding oocytes that go on to become good quality blastocysts, as compared to those that do not.

This research project was carried out in collaboration with Dr Lynne O’Shea in UCD. Our findings suggest that hormone levels in follicular fluid may be used to more sensitively and accurately predict how well an embryo will develop.

We would like to thank all the MFC patients who kindly took part in this research study.  This exciting development may aid us in further improving treatment outcomes in the future.

For more information, please see the link below:

https://www.ncbi.nlm.nih.gov/pubmed/31217014